Autonomic dysfunction and insulin resistance in type 2 diabetes mellitus with hypoglycemia unawareness: an
Debarshi Nandi1, Supriya Gupta2, Nasar Ajmera3
1Department of Physiology, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, Uttarakhand.
Purpose:
To evaluate the association between hypoglycemia unawareness, cardiac autonomic function, and insulin resistance in individuals with type2 diabetes, and explore potential correlations between autonomic dysfunction and metabolic parameters.
Methods:
50 individuals with type2 diabetes (age 50-65 years, duration >5 years) were recruited and classified into two groups using Clarke's Hypoglycemia Awareness Questionnaire: hypoglycemia unawareness group (n = 25) and controls (n = 25). Standardized cardiovascular autonomic function tests (AFTs) and short-term heart rate variability (HRV) analyses were performed. Autonomic dysfunction was graded using Ewing's, Bellavere's, and All India Institute of Medical Sciences AFT Lab criteria.
Results:
The hypoglycemia unawareness group exhibited significantly lower Valsalva ratio (1.49 ± 0.31) vs. the control group (1.80 ± 0.42) (P = 0.004), and reduced diastolic blood pressure (BP) response during the cold pressor test (10.92 ± 9.81 mmHg) vs. the control group (18.36 ± 8.50 mmHg) (P = 0.001). A greater fall in systolic BP during postural change was also noted (11.08 ± 6.38 mmHg) vs. the control group (7.64 ± 3.53 mmHg) (P = 0.037). HRV indices like SD of all N-N intervals and total power were reduced in hypoglycemia-unawareness individuals, indicating impaired sympatho-vagal modulation. Fasting glucose was significantly higher in hypoglycemia-unawareness individuals (114.36 ± 11.81) vs. the control group (106.44 ± 13.11) (P = 0.021), but no significant difference in homeostatic model assessment for insulin resistance was observed. Serum insulin levels showed negative correlations with sympathetic function measures.
Conclusion:
Hypoglycemia unawareness in T2DM is associated with combined sympathetic and parasympathetic dysfunction and reduced HRV, consistent with a hypoglycemia-associated autonomic failure cycle. Routine autonomic assessment may aid in early detection, risk stratification, and prevention of adverse cardiovascular outcomes in this high-risk subgroup.
More Related Videos
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Hypoglycemia and Glucagon
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
